AR044050A1 - Utilizacion de ivermectina para el tratamiento de desordenes dermatologicos - Google Patents

Utilizacion de ivermectina para el tratamiento de desordenes dermatologicos

Info

Publication number
AR044050A1
AR044050A1 ARP040101354A ARP040101354A AR044050A1 AR 044050 A1 AR044050 A1 AR 044050A1 AR P040101354 A ARP040101354 A AR P040101354A AR P040101354 A ARP040101354 A AR P040101354A AR 044050 A1 AR044050 A1 AR 044050A1
Authority
AR
Argentina
Prior art keywords
treatment
ivermectine
dermatological disorders
ivermectin
topical
Prior art date
Application number
ARP040101354A
Other languages
English (en)
Inventor
Vincent Manetta
Gary R Watkins
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33104376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR044050(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of AR044050A1 publication Critical patent/AR044050A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Utilización de ivermectina para la fabricación de una composición farmacéutica tópica destinada al tratamiento de la rosácea. Reivindicación 15: Composición tópica destinada al uso humano caracterizada porque es una emulsión que comprende: a) una fase aceitosa que comprende cuerpos grasos; b) al menos un emulsionante tensioactivo; c) ivermectina; d) un o varios solvente y/o propenetrante del activo; e) y agua. Reivindicación 20: Utilización de la composición de acuerdo con cualquiera de las reivindicaciones 15 a 19, para la preparación de un medicamento destinado al tratamiento de las afecciones dermatológicas.
ARP040101354A 2003-04-24 2004-04-22 Utilizacion de ivermectina para el tratamiento de desordenes dermatologicos AR044050A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0305048A FR2854074B1 (fr) 2003-04-24 2003-04-24 Utilisation de l'ivermectine pour le traitement de desordres dermatologiques

Publications (1)

Publication Number Publication Date
AR044050A1 true AR044050A1 (es) 2005-08-24

Family

ID=33104376

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101354A AR044050A1 (es) 2003-04-24 2004-04-22 Utilizacion de ivermectina para el tratamiento de desordenes dermatologicos

Country Status (11)

Country Link
US (6) US8815816B2 (es)
KR (1) KR101291824B1 (es)
CN (2) CN1777433A (es)
AR (1) AR044050A1 (es)
AT (1) ATE516037T1 (es)
DK (1) DK1620113T3 (es)
ES (1) ES2371945T3 (es)
FR (1) FR2854074B1 (es)
PT (1) PT1620113E (es)
SI (1) SI1620113T1 (es)
ZA (1) ZA200507346B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005020912D1 (de) 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
FR2883181B1 (fr) 2005-03-17 2007-05-18 Galderma Sa Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
EP2653160B1 (en) 2006-10-12 2017-09-27 Topaz Pharmaceuticals Inc. Topical ivermectin formulations and methods for elimination and prophylaxis of body lice
US7953614B1 (en) 2006-11-22 2011-05-31 Dr Systems, Inc. Smart placement rules
CA2741886C (en) * 2008-10-29 2018-05-01 Topaz Pharmaceuticals Inc. Preservative system for emulsion-based therapeutic topical formulations
CN102784166B (zh) * 2012-08-01 2015-11-25 青岛绿曼生物工程有限公司 治疗家畜螨虫病的复方伊维菌素组合物及其制备方法
CN103356687B (zh) 2012-10-19 2016-06-01 厦门大学 一种伊维菌素及其衍生物的用途
US9233118B2 (en) * 2013-07-08 2016-01-12 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
EP3074021B1 (en) 2013-11-29 2021-05-12 Galderma SA Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis
WO2015144907A1 (fr) 2014-03-28 2015-10-01 Galderma Research & Development Mousse chimique non rincée contenant du peroxyde de benzoyle
CN104127334A (zh) * 2014-08-19 2014-11-05 杨人源 一种杀菌除螨宠物香波
EP3220903A1 (fr) 2014-11-20 2017-09-27 Galderma S.A. Compositions comprenant un compose de la famille des avermectines et un compose agoniste d'au moins un des recepteurs de l'acide retinoique pour le traitement de l'acne
FR3041538B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041541B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee comprenant de l'ivermectine
FR3041540B1 (fr) * 2015-09-29 2018-10-26 Galderma Research & Development Composition nettoyante auto-moussante a rincer, contenant de l'ivermectine.
FR3041537B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant de la brimonidine et son utilisation dans le traitement de la rosacee.
FR3041535B1 (fr) 2015-09-29 2019-01-25 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
FR3041536B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne.
FR3041539B1 (fr) 2015-09-29 2018-10-26 Galderma Research & Development Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
WO2017064205A1 (en) * 2015-10-13 2017-04-20 Galderma Sa A process for preparing a stable emulsion comprising one or more avermectins
WO2018060870A1 (en) * 2016-09-30 2018-04-05 Aurobindo Pharma Limited Pharmaceutical composition of ivermectin and process for preparation thereof
TR201714097A2 (tr) * 2017-09-22 2018-10-22 Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Ticaret Anonim Sirketi İvermekti̇n topi̇k formülasyon
BR112020012018A2 (pt) 2017-12-15 2020-11-24 Tarsus Pharmaceuticals, Inc. formulações de parasiticida de isoxazolina e métodos para tratar blefarite
WO2019136221A1 (en) * 2018-01-05 2019-07-11 Attillaps Holdings Treating autoimmune disorders with chloroquine and/or hydroxychloroquine
WO2019152560A1 (en) * 2018-01-31 2019-08-08 Bio33 Degrees, Inc. Compositions and methods for topical treatment of dermal and ocular conditions
CN108272750A (zh) * 2018-04-25 2018-07-13 菏泽学院 一种治疗动物皮肤疥癣病的软膏剂及其制备方法
WO2021247283A1 (en) * 2020-06-04 2021-12-09 Amcyte Pharma, Inc. Delivery of aerosolized micromolar composition concentrations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA06863A (fr) 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
FR2725369B1 (fr) * 1994-10-07 1997-01-03 Oreal Composition cosmetique ou dermatologique constituee d'une emulsion huile dans eau a base de globules huileux pourvus d'un enrobage cristal liquide lamellaire
US5656280A (en) 1994-12-06 1997-08-12 Helene Curtis, Inc. Water-in-oil-in-water compositions
AU713580B2 (en) 1995-09-25 1999-12-02 Merial Ltd Anthelmintic macrocyclic lactone compositions
FR2754452B1 (fr) 1996-10-11 2003-02-14 Oreal Emulsion h/e a forte teneur en electrolytes et leur utilisation en dermo-cosmetique, notamment pour traiter les phenomenes d'irritation et/ou de peaux sensibles
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6521237B2 (en) * 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition
FR2787322B1 (fr) 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
US6133310A (en) * 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6399652B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
US6319945B1 (en) * 2000-06-29 2001-11-20 L. Dean Parks Method of treatment of seborrheic dermatitis
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
WO2003066009A1 (en) 2002-02-08 2003-08-14 Merck & Co., Inc. Topical ivermectin composition
CN1649578A (zh) 2002-03-04 2005-08-03 戴弗根斯公司 杀线虫的脂肪酸和脂肪酸酯相关化合物
RU2350333C3 (ru) 2003-04-24 2018-08-24 Галдерма С.А. Применение ивермектина для лечения дерматологических расстройств
FR2867684B1 (fr) 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
DE602005020912D1 (de) 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme

Also Published As

Publication number Publication date
ES2371945T3 (es) 2012-01-11
FR2854074B1 (fr) 2007-11-23
US20150306124A1 (en) 2015-10-29
KR20120062028A (ko) 2012-06-13
ATE516037T1 (de) 2011-07-15
US20170281663A1 (en) 2017-10-05
KR101291824B1 (ko) 2013-07-31
US20150306027A1 (en) 2015-10-29
US20170281664A1 (en) 2017-10-05
CN103800353A (zh) 2014-05-21
CN1777433A (zh) 2006-05-24
ZA200507346B (en) 2006-08-30
SI1620113T1 (sl) 2011-10-28
US11033565B2 (en) 2021-06-15
PT1620113E (pt) 2011-09-12
DK1620113T3 (da) 2011-09-12
US8815816B2 (en) 2014-08-26
US20140336139A1 (en) 2014-11-13
US20140051653A1 (en) 2014-02-20
FR2854074A1 (fr) 2004-10-29

Similar Documents

Publication Publication Date Title
AR044050A1 (es) Utilizacion de ivermectina para el tratamiento de desordenes dermatologicos
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
CL2017002939A1 (es) Composiciones farmacéuticas tópicas
AR035131A1 (es) Composiciones topicas y metodos para el tratamiento del dolor
AR012304A1 (es) Composiciones y metodos para el tratamiento de enfermedades intestinales inflamatorias y el uso de dicha composicion para preparar medicamentos paradichos tratamientos.
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
CO2021000174A2 (es) Composiciones tópicas para el alivio del dolor
CO6640250A2 (es) Formulación tópica que comprende (r)-3-ciclopentil-3-(4-(7h-pirrolo(2,3-d)pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo o una sal farmaceúticamente aceptable del mismo y una emulsión de aceite en agua
CL2011002053A1 (es) Composicion farmaceutica de espuma en aerosol en emulsion de aceite en agua que comprende un agente farmaceuticamente activo, agua, aceite, disolvente organico, componente tensoactivo, y propulsor; procedimiento de preparacion; uso para tratar enfermedades, o afecciones de la piel.
RU2350333C3 (ru) Применение ивермектина для лечения дерматологических расстройств
BRPI0411306A (pt) composições farmacêuticas compreendendo compostos ativos de vitamina d
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
AR033688A1 (es) Composicion parenteral reconstituible
EE200200500A (et) Uus iseemulgeeruv ravimi manustamise süsteem
BR0213128A (pt) Emulsificantes de sal de ibuprofeno e formulações de creme contendo os mesmos
DK1267831T3 (da) Hidtil ukendt selvemulgerende system til lægemiddelindgift
BR0318343A (pt) composição tópica para administração transdérmica
CL2009000980A1 (es) Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006).
AR110250A1 (es) Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida
DE602004020488D1 (de) Mikroemulsionen von retinoiden und diese enthaltende pharmazeutische zusammensetzungen
SE0102993D0 (sv) New self emulsifying drug delivery system
ES2129448T3 (es) Uso de 2-(2-nitro-4-trifluorometilbenzoil)-1,3-ciclohexanodiona en el tratamiento de tirosinemia y composiciones farmaceuticas.
PA8549401A1 (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
AR046146A1 (es) Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso

Legal Events

Date Code Title Description
FC Refusal